Condition

17p Deletion (1)

Cancer of the Blood and Bone Marrow (1)

Chronic Lymphocytic Leukemia (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

AbbVie (1)

Collaborator

Genentech, Inc. (1)

Intervention

abt-199 (main cohort) (1)

abt-199 (safety expansion cohort) (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

17p deletion

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

Completed

Chronic Lymphocytic Leukemia
+2 more

ABT-199 (Main Cohort)
ABT-199 (Safety Expansion Cohort)

Tucson, Arizona
+47 more

Nov 19, 2021